Progesterone Related Published Studies
Well-designed clinical trials related to Progesterone
Oral micronized progesterone for prevention of preterm birth. [2008.10.15]
Progesterone supplementation during cryopreserved embryo transfer cycles: efficacy and convenience of two vaginal formulations. [2008.09]
Progesterone in traumatic brain injury: time to move on to phase III trials. [2008.05.29]
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. [2008.05.20]
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. [2008.05]
Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial. [2008.05]
Effect of prostaglandin F2alpha at the time of AI on progesterone levels and pregnancy rate in synchronized Italian Mediterranean buffaloes. [2008.05]
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. [2008.04.30]
Synchronization of follicular wave emergence in the seasonally anestrous ewe: the effects of estradiol with or without medroxyprogesterone acetate. [2008.04.15]
Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. [2008.04]
Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use. [2008.04]
Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study. [2008.04]
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. [2008.03.20]
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. [2008.03.20]
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. [2008.03.01]
Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial. [2008.03]
Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. [2008.02]
Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. [2008.02]
Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin. [2008.02]
Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial. [2008.02]
Effect of early luteolysis in progesterone-based timed AI protocols in Bos indicus, Bos indicus x Bos taurus, and Bos taurus heifers. [2008.01.15]
Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers. [2008]
Progesterone in traumatic brain injury: time to move on to phase III trials. [2008]
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. [2008]
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial. [2007.12.01]
Pregnancy rates in lactating dairy cattle following supplementation of progesterone after artificial insemination. [2007.11]
How progesterone impairs memory for biologically salient stimuli in healthy young women. [2007.10.17]
Repeated induction of abortion in bitches and the effect on plasma concentrations of relaxin, progesterone and estradiol-17beta. [2007.10.01]
Progesterone effects on cocaine use in male cocaine users maintained on methadone: A randomized, double-blind, pilot study. [2007.10]
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. [2007.10]
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. [2007.10]
Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. [2007.10]
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. [2007.10]
A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature. [2007.10]
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. [2007.09.01]
Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. [2007.09]
Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study. [2007.09]
Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study. [2007.09]
Progesterone and the risk of preterm birth among women with a short cervix. [2007.08.02]
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. [2007.08.02]
Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women's Health, Osteoporosis, Progestin, Estrogen (HOPE) trial. [2007.08]
Progesterone and caspase-3 activation in equine cyclic corpora lutea. [2007.08]
The effect of progesterone and oestradiol benzoate on fertility of artificially inseminated repeat-breeder dairy cows during summer. [2007.08]
Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study. [2007.08]
Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users. [2007.07]
Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo controlled trial. [2007.06.19]
Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial. [2007.06.19]
Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. [2007.06.15]
The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. [2007.06]
A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. [2007.06]
Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. [2007.06]
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. [2007.05.20]
Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. [2007.05]
Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy. [2007.05]
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. [2007.04]
The effect of a progesterone releasing intravaginal device (PRID) on pregnancy risk to fixed-time insemination following diagnosis of non-pregnancy in dairy cows. [2007.03.15]
Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. [2007.03]
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. [2007.03]
Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone. [2007.03]
Progesterone acutely increases LH pulse amplitude but does not acutely influence nocturnal LH pulse frequency slowing during the late follicular phase in women. [2007.03]
Effect of oestradiol and progesterone replacement on bronchopulmonary dysplasia in extremely preterm infants. [2007.03]
Exogenous oestradiol and progesterone administration does not cause oedema in healthy young women. [2007.03]
A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. [2007.02.16]
Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. [2007.02]
Ovarian, hormonal, and reproductive events associated with synchronization of ovulation and timed appointment breeding of Bos indicus-influenced cattle using intravaginal progesterone, gonadotropin-releasing hormone, and prostaglandin F2alpha. [2007.01]
Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate. [2007.01]
Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. [2007.01]
[Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol] [2007]
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863). [2006.12]
Progesterone Receptor Modulator for Emergency Contraception: A Randomized Controlled Trial. [2006.11]
Pharmacokinetics and safety of tanaproget, a nonsteroidal progesterone receptor agonist, in healthy women. [2006.11]
Synchronization of estrus and artificial insemination in replacement beef heifers using gonadotropin-releasing hormone, prostaglandin F2alpha, and progesterone. [2006.11]
Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. [2006.11]
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. [2006.11]
Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. [2006.11]
Oral progesterone decreases saccadic eye velocity and increases sedation in women. [2006.11]
Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. [2006.10]
Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. [2006.10]
Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. [2006.10]
Conception rates and serum progesterone concentration in dairy cattle administered gonadotropin releasing hormone 5 days after artificial insemination. [2006.10]
ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury. [2006.09.28]
Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. [2006.09]
The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. [2006.08]
Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone. [2006.08]
Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. [2006.07]
Diet-induced alterations in progesterone clearance appear to be mediated by insulin signaling in hepatocytes. [2006.05]
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. [2006.05]
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. [2006.03.20]
Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate. [2006.03]
The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. [2006.03]
Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate. [2006.03]
Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. [2006.03]
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma. [2006.02.20]
Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women. [2006.02.20]
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. [2006.02]
Influence of different doses of progesterone treatments on ovarian follicle status in beef cows. [2006.02]
Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. [2006.01]
Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. [2005.12]
Transdermal progesterone cream as an alternative progestin in hormone therapy. [2005.11]
Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia menopause (PAM) study. [2005.11]
[Modification of C3 and C4 levels after the administration of conjugated estrogens plus medroxiprogesterone or raloxifene in postmenopausal women] [2005.10]
|
